Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia
- 31 July 2009
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 45 (10), 1877-1889
- https://doi.org/10.1016/j.ejca.2009.04.005
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Bim and Bad mediate imatinib-induced killing of Bcr/Abl + leukemic cells, and resistance due to their loss is overcome by a BH3 mimeticProceedings of the National Academy of Sciences of the United States of America, 2006
- Low-Level Expression of Proapoptotic Bcl-2–Interacting Mediator in Leukemic Cells in Patients with Chronic Myeloid Leukemia: Role of BCR/ABL, Characterization of Underlying Signaling Pathways, and Reexpression by Novel Pharmacologic CompoundsCancer Research, 2005
- Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cellsOncogene, 2005
- Roles of Bim in Apoptosis of Normal and Bcr-Abl-Expressing Hematopoietic ProgenitorsMolecular and Cellular Biology, 2004
- Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XLThe Journal of Experimental Medicine, 2000
- A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project GroupJNCI Journal of the National Cancer Institute, 1998
- Bcl-2-independent Bcr–Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xLOncogene, 1998
- Bim: a novel member of the Bcl-2 family that promotes apoptosisThe EMBO Journal, 1998
- Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemiaBlood, 1994
- Prognostic discrimination in "good-risk" chronic granulocytic leukemiaBlood, 1984